ZOMBIE Act

What happened and its current status: On April 29, 2026, the House Committee on Oversight and Government Reform ordered HR8467, the ZOMBIE Act (Zeroing Out Monetary Benefits Improperly Expended Act), to be reported favorably by a unanimous 40-0 vote. The bill was introduced on April 23, 2026 by Rep. Gary Palmer (R-AL) and referred to committee. It now awaits floor action in the House. The bill has not yet passed the House or Senate, and has not been signed into law.

The money trail: This bill authorizes zero dollars. It is a government operations reform bill that amends existing law (Payment Integrity Information Act of 2019) to require executive agencies to report improper payments resulting in financial loss to the government. It does not create any spending programs, tax credits, grants, or procurement mandates. The bill's mechanism is entirely procedural — it changes definitions and reporting requirements for federal agencies.

Structural winners and losers: There are no direct winners or losers among publicly traded companies. The bill targets internal government accounting and fraud prevention processes. It does not affect any private sector contracts, subsidies, or regulatory frameworks. Companies that provide government financial management software or fraud detection services (e.g., $ACN, $IBM, $SAIC) could see indirect, minimal, and speculative benefits if agencies increase spending on compliance systems, but the bill itself does not mandate or fund such spending.

Competitive landscape: Not applicable — no sector or company is directly impacted.

Timeline: The bill has cleared committee and awaits a floor vote in the House. If passed, it would need Senate approval and presidential signature. Given the unanimous committee vote and bipartisan nature of payment integrity reform, passage is plausible but timing is uncertain. Even if enacted, the bill creates no new revenue streams for any public company.